Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to catch hidden malnutrition in chemo patients

NCT ID NCT07163286

Knowledge-focused Sponsor: Çanakkale Onsekiz Mart University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at 200 adults with solid tumors who are getting chemotherapy. Researchers will compare four different checklists (PG-SGA, MUST, Nutriscore, and GLIM criteria) to see which best identifies malnutrition and muscle loss. The goal is to find the most reliable tool so doctors can offer nutritional help sooner. No new drugs or treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better identify cancer patients at risk of malnutrition and muscle loss, leading to earlier nutritional support.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve patient outcomes, and results may not apply to all cancer types or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will include approximately 150 adult outpatients (≥18 years) diagnosed with solid tumors (e.g., breast, lung, gastrointestinal, gynecologic cancers) who are currently receiving chemotherapy. Participants must have undergone or be scheduled for an abdominal CT scan within the last 3 months and must be physically and mentally capable of completing the assessments. Hospitalized patients and those with hematologic malignancies will be excluded.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Diagnosed with a solid tumor (e.g., breast, lung, GI, gynecologic cancers) * Receiving active outpatient chemotherapy * Recent abdominal CT scan within the last 3 months or planned * Provided written informed consent * Physically and mentally able to complete study procedures Exclusion Criteria: * Declined or unable to give informed consent * Cognitive impairment or mental status preventing participation * Neuromuscular diseases affecting muscle mass (e.g., myopathy, MND, severe neuropathy) * Inadequate CT image quality for L3 analysis * Acute infection or illness within the past month * Upper limb deformity or severe pain preventing handgrip testing * Incomplete assessments or withdrawal of consent during the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chemotherapeutic agent toxicity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chemotherapy-induced toxicity neoplasm Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chemotherapeutic agent toxicity Nutrition aspect of cancer Sarcopenia

Contacts and locations

Locations

  • Çanakkale Onsekiz Mart University

    Çanakkale, 17020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.